Search for other works by this author on: ...

Ariel University, Ari'el, Israel.

1Manchester Cancer Research Centre (MCRC), Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.

Telix Pharmaceuticals announced that TLX101 (131 I-iodofalan) increased median overall survival (OS) for patients with high-grade glioma, when compared against median OS without the drug. In the phase ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

1Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York.

1Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2Division of Life Sciences and Medicine, Department of Urology, the First Affiliated ...

10Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China. 11National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, ...

1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...

1Oncology Drug Discovery Unit, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts. *Corresponding Author: Adnan O. Abu-Yousif, Oncology Drug ...

Copyright held by the owner/author(s).